Ionis制药公司（NASDAQ：IONS）报告季度每股亏损$(0.66)，优于分析师普遍预期的$(1.10)，提升了40%。与去年同期每股亏损$(0.06)相比，这一数字大幅下降了1000%。公司报告季度销售额为$2.27亿，高于分析师普遍预期的$1.376亿，提升了64.97%。与去年同期的销售额$3.25亿相比，这一数字下降了30.15%。

以上内容来自Benzinga Earnings专栏，原文如下：

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(1.10) by 40 percent. This is a 1000 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $227.00 million which beat the analyst consensus estimate of $137.60 million by 64.97 percent. This is a 30.15 percent decrease over sales of $325.00 million the same period last year.